Private Portfolio Partners’s Elevance Health ELV Stock Holding History

Private Portfolio Partners’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-894	Closed	-$321K	–	261
2021 Q1	$321K	Hold	894	–	–	0.1%	179
2020 Q4	$287K	Buy	894 +4	+0.4%	+$1.23K	0.1%	174
2020 Q3	$239K	Hold	890	–	–	0.1%	177
2020 Q2	$234K	Sell	890 -597	-40%	-$159K	0.11%	165
2020 Q1	$337K	Hold	1,487	–	–	0.18%	124
2019 Q4	$449K	Buy	1,487 +5	+0.3%	+$1.38K	0.19%	114
2019 Q3	$356K	Buy	1,482 +496	+50%	+$136K	0.17%	129
2019 Q2	$278K	Buy	986 +251	+34%	+$68.6K	0.12%	175
2019 Q1	$211K	Buy	+735	New	+$213K	0.11%	183

Other funds holding ELV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Private Portfolio Partners's ELV Position: Q2 2021 in Review

Private Portfolio Partners sold out of Elevance Health (ELV) in Q2 2021, closing a stake of 894 shares — an estimated $321K sold.

Private Portfolio Partners first reported a position in ELV in Q1 2019 and held it in 9 quarters. The position peaked at $449K in Q4 2019. 1,234 funds tracked by Wall St. Rank hold ELV as of Q2 2021.

Private Portfolio Partners reported no remaining Elevance Health position as of Q2 2021 after selling out during the quarter.
Private Portfolio Partners sold 894 Elevance Health shares in Q2 2021, an estimated $321K.
Private Portfolio Partners first reported a position in Elevance Health in Q1 2019 and held it in 9 quarters.
Private Portfolio Partners's Elevance Health position peaked at $449K in Q4 2019.
1,234 funds tracked by Wall St. Rank held Elevance Health as of Q2 2021.

Based on Private Portfolio Partners's 13F filing for Q2 2021, filed 11 Aug 2021.